Response to oxaliplatin in CCD-18Co
Source: NCBI BioProject (ID PRJNA750430)

0 0

Project name: Response to oxaliplatin in CCD-18Co
Description: We obtained the gene expression signature from oxaliplatin-treated fibroblasts and quantified the association of oxaliplatin-activated fibroblasts with disease progression in colorectal cancer.Overall design: CCD-18Co cells were treated with oxaliplatin (100 µM) for 6 days. Gene expression profiles from treated and control cells were measured in duplicate using Affymetrix PrimeView human gene expression arrays.
Data type: Transcriptome or Gene expression
Sample scope: Multiisolate
Relevance: Medical
Organization: Hospital del Mar Medical Research Institute (IMIM)
Last updated: 2021-07-28